Griffiths Graham 4
4 · Barinthus Biotherapeutics plc. · Filed Jan 4, 2024
Insider Transaction Report
Form 4
Griffiths Graham
Chief Business Officer
Transactions
- Award
Share Option (Right to Buy)
2024-01-02+96,500→ 96,500 totalExercise: $3.70Exp: 2034-01-02→ Ordinary Shares (96,500 underlying)
Footnotes (2)
- [F1]The shares underlying this option shall vest and become exercisable in three equal annual installments, with the first installment vesting on January 2, 2025.
- [F2]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.